Related Experiment Video
Updated: Jul 16, 2026

A Single-Channel and Non-Invasive Wearable Brain-Computer Interface for Industry and Healthcare
Published on: July 7, 2023
Value of the critical flicker frequency in patients with minimal hepatic encephalopathy
Manuel Romero-Gómez1, Juan Córdoba, Rodrigo Jover
1Unit for the Clinical Management of Digestive Diseases, Hospital Universitario de Valme, Sevilla, Spain. mromerog@supercable.es
Unlabelled:
Minimal hepatic encephalopathy (MHE) is mainly diagnosed using psychometric tests such as the psychometric hepatic encephalopathy score (PHES). Despite the clinical and social relevance of MHE, psychometric testing is not widespread in routine clinical care. We assessed the usefulness of the critical flicker frequency (CFF), for the diagnosis of MHE and for the prediction of the development of overt episodes of HE. The normal range of PHES in the Spanish population was evaluated in a control group. Subsequently, 114 patients with cirrhosis and 103 healthy controls underwent both PHES and CFF tests. A diagnosis of MHE was made when the PHES was lower than -4 points. Patients were followed-up every 6 months for a total of 1 year. CFF did not correlate with age, education, or sex in the control group. The mean CFF was significantly lower in patients with MHE versus non-MHE or controls. Mean CFF correlated with individual psychometric tests as well as PHES (r = 0.54; P < 0.001). CFF <38 Hz was predictive of further bouts of overt HE (log-rank: 14.2; P < 0.001). There was a weak correlation between mean CFF and Child-Pugh score but not with model for end-stage liver disease score. In multivariate analysis using Cox regression, CFF together with Child-Pugh score was independently associated with the development of overt HE.
Conclusion:
CFF is a simple, reliable, and accurate method for the diagnosis of MHE. It is not influenced by age or education and could predict the development of overt HE.
Insights
Critical flicker frequency (CFF) is a simple and accurate tool for diagnosing minimal hepatic encephalopathy (MHE). This test can also predict the development of overt hepatic encephalopathy (HE) in patients with cirrhosis.
Area of Science:
- Hepatology
- Neuroscience
- Clinical Diagnostics
Background:
- Minimal hepatic encephalopathy (MHE) impacts patients with cirrhosis, but current diagnostic psychometric hepatic encephalopathy scores (PHES) are not widely used in clinical practice.
- Accurate and accessible diagnostic tools are needed to identify MHE and predict its progression.
Purpose of the Study:
- To evaluate the utility of critical flicker frequency (CFF) for diagnosing MHE in patients with cirrhosis.
- To assess CFF's ability to predict the development of overt hepatic encephalopathy (HE).
Main Methods:
- 114 patients with cirrhosis and 103 healthy controls underwent CFF and PHES testing.
- MHE was diagnosed using PHES < -4. Patients were followed for 1 year to monitor for overt HE.
- Correlation and regression analyses were used to assess CFF's diagnostic and predictive capabilities.
Main Results:
- Mean CFF was significantly lower in patients with MHE compared to non-MHE patients and controls.
- CFF showed a significant correlation with PHES (r = 0.54, P < 0.001).
- CFF < 38 Hz predicted the development of overt HE (log-rank: 14.2; P < 0.001) and was independently associated with overt HE development when combined with Child-Pugh score.
Conclusions:
- CFF is a simple, reliable, and accurate method for diagnosing MHE.
- CFF is not influenced by age or education, making it a practical diagnostic tool.
- CFF can predict the future development of overt HE in patients with cirrhosis.
Related Concept Videos
Hepatic Encephalopathy
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

